Jump to content


Want to join the discussions?

Sign up for a free membership! 

If you are a member already, log in!

(lost your password? reset it here)

99nicu.org 99nicu.org

Stefan Johansson

  • Content Count

  • Joined

  • Last visited

  • Days Won

  • Country


Stefan Johansson last won the day on October 13

Stefan Johansson had the most liked content!

Community Reputation

486 Excellent

About Stefan Johansson

  • Rank
    99nicu Team
  • Birthday 06/20/1966

Profile Information

  • First name
  • Last name
  • Gender
  • Occupation
    consultant neonatologist, associate professor
  • Affiliation
    Sachs Children's Hospital
  • Location
    Stockholm, Sweden

Recent Profile Visitors

17,658 profile views
  1. We measure axillary temps (most often parents do it )
  2. We also practise some manipulation in preterm infants but only if otherwise well (preterm infants with functional GI problems) - if we suspect NEC, manipulation is a no-no. This practise is usually not a doctor's decision, usually nursing staff decide to do this if they believe it helps.
  3. until

    Anyone else coming to jENS? I am coming and would be great to meet up with other 99nicu members! I will mostly be in the "startup"-part of the exhibition (with Neobiomics) - come by and we make a plan!
  4. Many of you already know about my engagement in Neobiomics, a startup company now launching ProPrems® in Europe. I was asked recently if there was a specific event that made me committed to close the gap between need and availability of a safe way to support the intestinal microbiota. Yes, there was a “Tipping Point” that I can share a few words about, without disclosing patient data. The photo below shows the place in my NICU where a preterm infant stayed some years back, being well on full feeds and expected to have an easy journey with us. When things went into new and unfortunate directions. Although difficulties and suffering is part of what we work with, this event made me feel that I did not provide the best care for my patients. I mean, compared to all interventions we make every other day, and the lack of good evidence for many of them, probiotics supplementation was already in 2014 a no-brainer from an EBM perspective. So, I set off to find a suitable product. But became increasingly frustrated. I thought that manufacturing probiotics could not be rocket science but I experienced that no company could provide what I was looking for. Specifically, when it came to documentation around quality. I discussed this matter with colleagues and realized that I shared my concerns with others. An idea came to my mind that maybe we should just work out a solution ourselves, within the neonatal community. Philipp Novak, a life-science entrepreneur in Austria, was brave enough to get convinced and off we went. Backed by a group of clinicians and researchers. In 2016 we founded the startup company Neobiomics and initiated our collaboration with Chr.Hansen, world-leading manufacturer of bacterial cultures. And now, after 1000s of work hours (pro bono BTW) and with very limited funds, we have now reached the first goal. With ProPrems® there is now a premium product available, with manufacturing quality as we want it (single-dose-packaging, 2y stability in room temp, tested against an extended panel of contaminants, no risk of antibiotic resistance gene transfer). What’s next? To speak in symbols, our plane is on the takeoff strip at full throttle while we are still putting the wings together. So times are both hectic and thrilling. But like when standing in front of a very ill infant in the NICU, I feel that this is something we can manage by systematic and hard work. But of course, ProPrems® needs to find the way out to NICUs. Without a costly "old-school" organization of sales rep’s etc, this may seem challenging. But given the collegial feedback so far, we feel confident our project will sustain. If you get interested to learn more, find more in the attached folder. You can also visit the web sites neobiomics.eu and proprems.eu, or get in touch with me directly at stefan@neobiomics.eu. But please note that ProPrems® will be only available in Europe (that’s why access to ProPrems.eu is restricted from non-EU countries). ProPrems_Folder.pdf
  5. @Rola alzir thanks for your comment. I am not aware of any data supporting the use of ranitidin (or other anti-acid drugs) with ibuprogen. In general, the use of anti-acids seems to have few (if any) positive effects, but side-effects. Read the blog post below by Keith Barrington (from 2013 but still relevant) and when it comes to GERD, check out the document by ESPGHAN https://neonatalresearch.org/2013/12/06/acid-suppression-doesnt-work-and-its-not-safe-phunny-how-we-got-here/ https://www.ncbi.nlm.nih.gov/pubmed/29470322
  6. Found this discussion on Researchgate! Did not know they also had a forum there. Lots of good comments. I was taught during my training that reducing dead space is the reason for vittring tubes. But as pointed out, the volume of the cut tub piece is so small that it would have no practical significance, even for an ELBW infant. But I still do it, it is in my ”auto-pilot”... https://www.researchgate.net/post/Will_it_be_better_to_cut_the_ET_tube_a_few_centimeters_after_tube_is_in_place_and_then_place_the_connector
  7. @bimalc good point about as to whether a surgeon would be consulted. We always discuss those cases with the surgeons, they want to keep updated and don't like to be surprised if there is a deterioration (and we really need them...) In my experience, those we work with are not liberal with interventions, so consultations do not "complicate" the management. But I suppose this may well be a possibility that more surgical consultations also "drive" the rate of surgical interventions. Would be great from other members about this!
  8. Although the photo is a bit low-pixelated, it looks like rather extensive intramural gas, i.e. NEC. Suggest stopping feeds, TPN and antibiotics. Follow the clinical course and consult your ped surgeon.
  9. Good question! This systematic review on heart rates in children clearly shows the decline: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789232/ To be honest, I don't know exactly the underlying mechanisms behind, but I suppose it may be related to both the autonomic drive (symp/parasymp), and that HR is a more important factor for cardiac output during infancy than later in life. Anyone else knowing more of basic physiology than I do ?
  10. @ChantalNICU I suppose there could be variations, this is the Stockholm version
  11. @ChantalNICU Sorry for the delay... (yes, I had forgotten ) this is the written guideline: after preparation, the pumpsyringe and tubings are filled and kept for 20min. Then the tubings are flushed with the solution and then connected to the patient.
  12. Check out this blog post by @AllThingsNeonatal Myself, I must admit I have no experience at all of erythropoetin
  13. Same here - although maternal smoking is less prevalent nowadays, we have/do not managed infants differently. Although smoking is related to preterm birth as such (see for example https://www.ncbi.nlm.nih.gov/pubmed/15901269) - my personal experience is not that maternal smoking would (as such) relate to severity of respiratory morbidity.
  14. Thanks so much for your feedback And, it is really all members, like you @tarek that "create" the content and the athmosphere by sharing expertise and experiences. Without that, the would be no community.
  • Create New...